Date of download: 9/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: 5-Year Clinical Outcomes of the ARTS II (Arterial.

Slides:



Advertisements
Similar presentations
PCI VS CABG JOURNAL REVIEW
Advertisements

Arterial Revascularization Therapies Part II: a non- randomized comparison of contemporary PCI and coronary artery bypass grafting (CABG) in patients with.
ISAR-CABG Objective To compare the efficacy of DES with BMS in a randomized trial powered for clinical events Sample 610 patients with de novo SVG lesions.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Omega-3 Polyunsaturated Fatty Acids and Cardiovascular.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prospective Application of Pre-Defined Intravascular.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Safety and Efficacy of Low Blood Pressures Among.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: AACVPR/ACC/AHA 2007 Performance Measures on Cardiac.
Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Elevated Plasma Levels of Neuropeptide Proenkephalin.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: The impact of plasma levels of C-reactive protein,
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: A comparison of three-year survival after coronary.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship Between Operator Volume and Adverse.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prognostic value of coronary artery calcium screening.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Frequency and Practice-Level Variation in Inappropriate.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prediction of Cardiac Events in Patients With Reduced.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prognostic Value of Cardiac Computed Tomography.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Smoking Is Associated With Adverse Clinical Outcomes.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Prognostic Value of N-Terminal Pro–B-Type Natriuretic.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pregnancy-associated plasma protein-A levels in.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: When to stress patients after coronary artery bypass.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implications of Introducing High-Sensitivity Cardiac.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implantation of a Drug-Eluting Stent With a Different.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Drug-Eluting Versus Bare-Metal Stents During PCI.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Paradigm shifts in cardiovascular medicine J Am.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Coronary Intervention Complications.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prevalence and Clinical Implications of Newly Revealed,
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical restenosis after coronary stenting: perspectives.
Date of download: 7/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Long-Term Outcomes of Older Diabetic Patients After.
Date of download: 7/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: The FRONTIER Stent Registry: Safety and Feasibility.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Value of Platelet Reactivity in Predicting Response.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Ventricular Arrhythmia After Cardiac Surgery: Incidence,
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Hypertrophic Cardiomyopathy in Adulthood Associated.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Long-Term Clinical Results Following Stenting of.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prognostic Value of Multislice Computed Tomography.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Comprehensive Meta-Analysis of Safety and Efficacy.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Randomized Trial of Paclitaxel- Versus Sirolimus-Eluting.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Benefit of Early Invasive Therapy in Acute Coronary.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Association of cardiac troponin, CK-MB, and postoperative.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship between heparin anticoagulation and.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Making Sense of Statistics in Clinical Trial Reports:
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Wearable Cardioverter-Defibrillator Use in Patients.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Risk of Stroke With Coronary Artery Bypass Graft.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Coronary Anatomy and Stenting Technique.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
From: Characterization of Plaque Prolapse After Drug-Eluting Stent Implantation in Diabetic Patients: A Three-Dimensional Volumetric Intravascular Ultrasound.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence and Correlates of Drug-Eluting Stent Thrombosis.
From: Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions: 2-Year Follow-Up From the Zilver PTX Randomized and Single-Arm.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association Between Endoscopic vs Open Vein-Graft.
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Characteristics and Long-Term Outcomes of Percutaneous.
From: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention:
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effectiveness of In-Laboratory High-Dose Clopidogrel.
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Asymptomatic Individuals With a Positive Family.
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Efficacy and Safety of Dual Antiplatelet Therapy.
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Drug-Eluting Versus Bare-Metal Stents.
Copyright © 2014 American Medical Association. All rights reserved.
Figure 1 Ischaemic endpoints
Figure 1 A flow chart describing the systematic process followed for article selection.  From: A systematic review of cost-effectiveness of percutaneous.
Copyright © 2013 American Medical Association. All rights reserved.
Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have.
Circ Cardiovasc Interv
Giuseppe Biondi Zoccai, MD
Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized.
Presentation transcript:

Date of download: 9/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: 5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus- Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions J Am Coll Cardiol. 2010;55(11): doi: /j.jacc Figure Legend: Flow Chart of 5-Year Follow-Up *Electrocardiogram (ECG) obtained by center. FUP = follow-up; GP = general practitioner.

Date of download: 9/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: 5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus- Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions J Am Coll Cardiol. 2010;55(11): doi: /j.jacc Figure Legend: Kaplan-Meier Curves of Freedom From Clinical Events Kaplan-Meier estimates up to 1,800 days of: (A) freedom from all-cause mortality; (B) freedom from a composite of death, cerebrovascular accident (CVA), or myocardial infarction (MI); (C) freedom from revascularization; and (D) freedom from major adverse cardiac and cardiovascular events (MACCE) (all-cause mortality, any MI, CVA, or any reintervention). ARTS = Arterial Revascularization Therapy Study; BMS = bare-metal stent(s); CABG = coronary artery bypass graft; SES = sirolimus-eluting stent(s).

Date of download: 9/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: 5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus- Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions J Am Coll Cardiol. 2010;55(11): doi: /j.jacc Figure Legend: Kaplan-Meier Curves of Freedom From ARC-Defined MACE, With or Without ST Kaplan-Meier estimates of freedom from death (red lines), death or myocardial infarction (MI) (orange lines), and major adverse cardiac events (MACE) (all-cause mortality, MI, or revascularization) (yellow lines) according to Academic Research Consortium (ARC) definition (A). Possible stent thrombosis (ST) is superimposed on the Kaplan-Meier curves as a triangle, probable stent thrombosis as a square, and definite stent thrombosis as a circle. If all these ST-related events had been eliminated (B), freedom from death at 5 years would have increased from 94.5% to 96.8%, freedom from death or death/MI from 84.3% to 92.7%, and freedom from MACE from 70.5% to 78.0%. Please note MI and MACE were readjudicated according to ARC definition. *All-cause death, MI, or any revascularization according to ARC definition. Troponin was not collected in the ARTS II.

Date of download: 9/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: 5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus- Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions J Am Coll Cardiol. 2010;55(11): doi: /j.jacc Figure Legend: Kaplan-Meier Curves of Freedom From MACCE According to Tertiles of SYNTAX Score Freedom from protocol-defined major adverse cardiac and cerebrovascular event (MACCE) rate according to SYNTAX score tertiles (A). When the coronary artery bypass graft (CABG) MACCE rate is superimposed, the lowest SYNTAX score tertile shows a similar event rate at 5 years (B).